Clinical Trial Update: A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM [Phase 1, Phase 2]

View source ↗

Summary

ALN-4324 is being studied in Phase 1/Phase 2 trials in overweight/obese adults, including patients with Type 2 Diabetes Mellitus, and the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ALN-4324

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Obese or Overweight Healthy Volunteers, Type 2 Diabetes Mellitus (T2DM) | Phase 1, Phase 2 | Status: RECRUITING